UniProt ID | ATG4A_HUMAN | |
---|---|---|
UniProt AC | Q8WYN0 | |
Protein Name | Cysteine protease ATG4A | |
Gene Name | ATG4A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 398 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Preferred substrate is GABARAPL2 followed by MAP1LC3A and GABARAP. Has also an activity of delipidating enzyme for the PE-conjugated forms.. | |
Protein Sequence | MESVLSKYEDQITIFTDYLEEYPDTDELVWILGKQHLLKTEKSKLLSDISARLWFTYRRKFSPIGGTGPSSDAGWGCMLRCGQMMLAQALICRHLGRDWSWEKQKEQPKEYQRILQCFLDRKDCCYSIHQMAQMGVGEGKSIGEWFGPNTVAQVLKKLALFDEWNSLAVYVSMDNTVVIEDIKKMCRVLPLSADTAGDRPPDSLTASNQSKGTSAYCSAWKPLLLIVPLRLGINQINPVYVDAFKECFKMPQSLGALGGKPNNAYYFIGFLGDELIFLDPHTTQTFVDTEENGTVNDQTFHCLQSPQRMNILNLDPSVALGFFCKEEKDFDNWCSLVQKEILKENLRMFELVQKHPSHWPPFVPPAKPEVTTTGAEFIDSTEQLEEFDLEEDFEILSV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Phosphorylation | TEKSKLLSDISARLW HHHHHHHHHHHHHHH | 43.25 | 17924679 | |
100 | Phosphorylation | RHLGRDWSWEKQKEQ HHHCCCCCHHHHHHC | 29.64 | - | |
111 | Phosphorylation | QKEQPKEYQRILQCF HHHCCHHHHHHHHHH | 14.82 | 26074081 | |
192 | Phosphorylation | MCRVLPLSADTAGDR HHCCCCCCCCCCCCC | 23.35 | 30576142 | |
195 | Phosphorylation | VLPLSADTAGDRPPD CCCCCCCCCCCCCCC | 32.05 | 30576142 | |
203 | Phosphorylation | AGDRPPDSLTASNQS CCCCCCCCCCCCCCC | 33.13 | 28555341 | |
205 | Phosphorylation | DRPPDSLTASNQSKG CCCCCCCCCCCCCCC | 31.80 | 27251275 | |
216 | Phosphorylation | QSKGTSAYCSAWKPL CCCCCHHCCCCCCCE | 6.16 | 30576142 | |
328 | Ubiquitination | GFFCKEEKDFDNWCS HCCCCCCCCCCCHHH | 65.86 | - | |
339 | Ubiquitination | NWCSLVQKEILKENL CHHHHHHHHHHHHHH | 38.96 | - | |
343 | Ubiquitination | LVQKEILKENLRMFE HHHHHHHHHHHHHHH | 50.66 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATG4A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATG4A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATG4A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ATGA1_HUMAN | ATG101 | physical | 24100292 | |
GBRL2_HUMAN | GABARAPL2 | physical | 12473658 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND MASSSPECTROMETRY. |